top of page
Search


Melanoma Trials Using Antibiotic or Microbiome Therapy Pretreatment Better Than Direct Combination
Early-phase melanoma trials testing microbiome approaches that leverage a broad- spectrum antibiotic or microbiome monotherapy before...


Evofem's Amphora Requires 12-month Data to Convince Experts of Contraceptive Efficacy
Evofem’s (NASDAQ:EVFM) contraceptive gel Amphora leaves experts needing detailed 12-month efficacy data despite available Phase III...

Haste Plus Speed: The Need to Ensure COVID-19 Vaccines Don't Make Infections Worse
By Sandi Wong, Assistant Editor "THERE IS A HUGH DIFFERENCE BETWEEN THE POSSIBILITY THAT A VACCINE WILL SENSITIZE A SUSCEPTIBLE,...
Issue21
January 2020 - April 2020 Boehringer Tngelheim, Enleofen Tnk $1B-Per-Product Anti-TL-11 Partnership Focused on NASH, Lung Disorders...
Issue21
North America American Society of Clinical Oncology 2020 Annual Meeting (ASCO 2020) May 29-June 2, 2020 | Chicago, Illinois, USA Website:...
ISSUE 21
FROM THE PUBLISHER Unprecedented fight against the novel coronavirus is taking place in the United States and the world. Government...

Hidden Consequences of COVID-19: Why Small Biotechs Can't Just Wait This One Out
By C. Simone Fishburn, Editor In Chief It’s still anyone’s guess as to how long the COVID-19 outbreak will take to peak, let alone wane...


Stanley Kim, J.D., Chief Executive Officer, WinSanTor
WinSanTor is a biotechnology company focused on the development of treatments for peripheral neuropathies (PN). Could you please explain...


Patrick Soon-Shiong, M.D., Chairman & Chief Executive Officer, NantWorks
Chairman and Chief Executive Officer, NantWorks Owner and Executive Chairman, Los Angeles Times and The San Diego Union-Tribune Dr....


David Ho, M.D.,Scientific Director & Chief Executive Officer at ADARC
Scientific Director and Chief Executive Officer, Aaron Diamond AIDS Research Center (ADARC) Irene Diamond Professor, The Rockefeller...
bottom of page